Topic: Pharma News
New with Topic: Pharma News
SteveWoodruff posted a blog entry
Impactiviti Daily 121809
This will be the final Impactiviti Daily for 2009. We’ll pick up again in the new year. Have a delightful holiday...
This will be the final Impactiviti Daily for 2009. We’ll pick up again in the new year. Have a delightful holiday...
SteveWoodruff posted a blog entry
Impactiviti Daily 121609
TODAY’S NEWSCrestor – now no high cholesterol needed!Ah, lawyers. NJ, the judicial hellhole. And, the video Pfizer...
TODAY’S NEWSCrestor – now no high cholesterol needed!Ah, lawyers. NJ, the judicial hellhole. And, the video Pfizer...
SteveWoodruff posted a blog entry
Impactiviti Daily 121409
TODAY’S NEWSSanofi - now laying off contract sales reps and some others.Pfizer and compliance. That’s a lot of...
TODAY’S NEWSSanofi - now laying off contract sales reps and some others.Pfizer and compliance. That’s a lot of...
SteveWoodruff posted a blog entry
Impactiviti Daily 121109
TODAY’S NEWSBone drugs may help prevent breast cancer? – New results from a landmark women’s health study raise...
TODAY’S NEWSBone drugs may help prevent breast cancer? – New results from a landmark women’s health study raise...
SteveWoodruff posted a blog entry
Impactiviti Daily 121009
TODAY’S NEWSSo…is Roche’s Tamiflu really that effective? – The effectiveness of Roche Holding AG’s...
TODAY’S NEWSSo…is Roche’s Tamiflu really that effective? – The effectiveness of Roche Holding AG’s...
SteveWoodruff posted a blog entry
Impactiviti Daily 120909
TODAY’S NEWSNovartis’ “son of Glivec” (Tasigna) carrying on the family tradition – Novartis has...
TODAY’S NEWSNovartis’ “son of Glivec” (Tasigna) carrying on the family tradition – Novartis has...
SteveWoodruff posted a blog entry
Impactiviti Daily 120809
TODAY’S NEWSNovartis gets FDA panel nod for transplant drug - A U.S. advisory panel recommended approval of a Novartis AG...
TODAY’S NEWSNovartis gets FDA panel nod for transplant drug - A U.S. advisory panel recommended approval of a Novartis AG...
SteveWoodruff posted a blog entry
Impactiviti Daily 120709
TODAY’S NEWSCelgene to buy Gloucester Pharmaceuticals, another company with a focus on developing drugs for blood cancer. I...
TODAY’S NEWSCelgene to buy Gloucester Pharmaceuticals, another company with a focus on developing drugs for blood cancer. I...
SteveWoodruff posted a blog entry
Impactiviti Daily 120109
Welcome back from Thanksgiving holiday! Can’t believe it’s already December…This will be the only...
Welcome back from Thanksgiving holiday! Can’t believe it’s already December…This will be the only...
SteveWoodruff posted a blog entry
Impactiviti Daily 112409
I wish all my readers and pharma-industry colleagues a wonderful Thanksgiving holiday!TODAY’S NEWSCephalon, Ception, and...
I wish all my readers and pharma-industry colleagues a wonderful Thanksgiving holiday!TODAY’S NEWSCephalon, Ception, and...
SteveWoodruff posted a blog entry
Impactiviti Daily 112309
It’s Thanksgiving week! We’ll plan on publishing the Daily on Monday/Tuesday, then take the rest of the week off...
It’s Thanksgiving week! We’ll plan on publishing the Daily on Monday/Tuesday, then take the rest of the week off...
SteveWoodruff posted a blog entry
Impactiviti Daily 112009
TODAY’S NEWSSo, have we been pursuing the wrong course for GERD all this time? Is it actually caused by immune system cells,...
TODAY’S NEWSSo, have we been pursuing the wrong course for GERD all this time? Is it actually caused by immune system cells,...
SteveWoodruff posted a blog entry
Impactiviti Daily 111709
Whew! The back-to-back conference marathon is now over, and we can get back to our regular pharma news reporting. Here’s...
Whew! The back-to-back conference marathon is now over, and we can get back to our regular pharma news reporting. Here’s...
SteveWoodruff posted a blog entry
Impactiviti Daily 110209
TODAY’S NEWSTakeda buys into Amylin’s weight-loss drug portfolio – Takeda will pay $75 million upfront for...
TODAY’S NEWSTakeda buys into Amylin’s weight-loss drug portfolio – Takeda will pay $75 million upfront for...
SteveWoodruff posted a blog entry
Impactiviti Daily 103009
TODAY’S NEWSFTC says “yes” to Merck-Schering merger.AstraZeneca’s experimental drug Brilinta may not get...
TODAY’S NEWSFTC says “yes” to Merck-Schering merger.AstraZeneca’s experimental drug Brilinta may not get...
SteveWoodruff posted a blog entry
Impactiviti Daily 102909
TODAY’S NEWSRoche: Our upcoming diabetes drug works better than Byetta. Will be interesting to see the full set of...
TODAY’S NEWSRoche: Our upcoming diabetes drug works better than Byetta. Will be interesting to see the full set of...
SteveWoodruff posted a blog entry
Impactiviti Daily 102809
Note: Impactiviti Daily is going to be published somewhat irregularly over the next couple of weeks, as we’re in the heart of...
Note: Impactiviti Daily is going to be published somewhat irregularly over the next couple of weeks, as we’re in the heart of...
SteveWoodruff posted a blog entry
Impactiviti Daily 101609
Note: Impactiviti Daily is going to be published somewhat irregularly over the next 4 weeks, as we’re in the heart of...
Note: Impactiviti Daily is going to be published somewhat irregularly over the next 4 weeks, as we’re in the heart of...
SteveWoodruff posted a blog entry
Impactiviti Daily 101409
TODAY’S NEWSB-I gets (European) clearance for extended-release Parkinson’s drug formulation.Avodart + Flomax –...
TODAY’S NEWSB-I gets (European) clearance for extended-release Parkinson’s drug formulation.Avodart + Flomax –...
SteveWoodruff posted a blog entry
Impactiviti Daily 100909
TODAY’S NEWSDrug market will top $825B next year (worldwide – that’s 4-6% growth). That’s a lot of...
TODAY’S NEWSDrug market will top $825B next year (worldwide – that’s 4-6% growth). That’s a lot of...
SteveWoodruff posted a blog entry
Impactiviti Daily 100809
What do you think? – Those Dreaded Capabilities Presentations: can we make the whole process better? My ideas – what...
What do you think? – Those Dreaded Capabilities Presentations: can we make the whole process better? My ideas – what...
SteveWoodruff posted a blog entry
Impactiviti Daily 100709
TODAY’S NEWSIt appears that there is virtually nothing of significant interest on the newswires today. Nada. Nyet. Dry well....
TODAY’S NEWSIt appears that there is virtually nothing of significant interest on the newswires today. Nada. Nyet. Dry well....
SteveWoodruff posted a blog entry
Impactiviti Daily 093009
TODAY’S NEWSNovartis’ new MS drug (FTY 720) looking good in Phase III trials. New results just released.Vertex...
TODAY’S NEWSNovartis’ new MS drug (FTY 720) looking good in Phase III trials. New results just released.Vertex...
SteveWoodruff posted a blog entry
Impactiviti Daily 092909
Where to get your overview of Social Media in Pharma? Right here: http://bit.ly/socialrxTODAY’S NEWSPharma’s new hot...
Where to get your overview of Social Media in Pharma? Right here: http://bit.ly/socialrxTODAY’S NEWSPharma’s new hot...
SteveWoodruff posted a blog entry
Google’s Sidewiki – Game-changer for Pharma Social Media?
Take a look at the screen shot below, from Pfizer’s homepage. Believe it or not, I, or anyone else, can now leave...
Take a look at the screen shot below, from Pfizer’s homepage. Believe it or not, I, or anyone else, can now leave...
SteveWoodruff posted a blog entry
Impactiviti Daily 092509
Tune in TODAY – I’ll be doing a live on-line interview on Social Media in Pharma with Paul Chaney – starts at...
Tune in TODAY – I’ll be doing a live on-line interview on Social Media in Pharma with Paul Chaney – starts at...
SteveWoodruff posted a blog entry
Impactiviti Daily 092109
See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to...
See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to...
SteveWoodruff posted a blog entry
Impactiviti Daily 091709
TODAY’S NEWSFDA backs Auxilium’s new drug Xiaflex.Which pharma companies have the best pipelines? Here’s the...
TODAY’S NEWSFDA backs Auxilium’s new drug Xiaflex.Which pharma companies have the best pipelines? Here’s the...
SteveWoodruff posted a blog entry
Impactiviti Daily 091609
TODAY’S NEWSOsteoporosis. The status of new treatments from Wyeth, Pfizer, and Amgen.FDA approves H1N1 vaccines - The Food...
TODAY’S NEWSOsteoporosis. The status of new treatments from Wyeth, Pfizer, and Amgen.FDA approves H1N1 vaccines - The Food...
SteveWoodruff posted a blog entry
Impactiviti Daily 090409
TODAY’S NEWSAbbott to acquire Visiogen for $400m…and, also named a top place to start your career.Meda - Astepro...
TODAY’S NEWSAbbott to acquire Visiogen for $400m…and, also named a top place to start your career.Meda - Astepro...
SteveWoodruff posted a blog entry
Impactiviti Daily 082009
TODAY’S NEWSFemara keeps breast cancer at bay better than tamoxifen – Novartis AG’s Femara prevented breast...
TODAY’S NEWSFemara keeps breast cancer at bay better than tamoxifen – Novartis AG’s Femara prevented breast...
SteveWoodruff posted a blog entry
Impactiviti Daily 081909
NEWSOne of Eli Lilly’s patents on Gemzar invalidated; may shave off 3 years of exclusivity – the method of use...
NEWSOne of Eli Lilly’s patents on Gemzar invalidated; may shave off 3 years of exclusivity – the method of use...
SteveWoodruff posted a blog entry
Today’s Top Pharma News 081009
After a couple weeks of vacation and stepping-back time, I’m once again pulling together the daily pharma news. Well,...
After a couple weeks of vacation and stepping-back time, I’m once again pulling together the daily pharma news. Well,...
SteveWoodruff posted a blog entry
Today’s Top Pharma News 071609
FDA to Zeltia: NO – An FDA advisory committee has handed Spain’s Zeltia a crushing blow, deciding against a...
FDA to Zeltia: NO – An FDA advisory committee has handed Spain’s Zeltia a crushing blow, deciding against a...
SteveWoodruff posted a blog entry
Today’s Top News in Pharma 071509
FDA to Watson on 24-week Trelstar: Ummm, not yet. Oh, and to Bayer and J&J for Xarelto: Ummmm, not yet.Bayer’s Yaz...
FDA to Watson on 24-week Trelstar: Ummm, not yet. Oh, and to Bayer and J&J for Xarelto: Ummmm, not yet.Bayer’s Yaz...
SteveWoodruff posted a blog entry
Today’s Top Pharma News 71309
Finally – FDA approves DSI/Lilly blood thinner Effient. Narrow indication with warnings, however – The approval...
Finally – FDA approves DSI/Lilly blood thinner Effient. Narrow indication with warnings, however – The approval...
